Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly.
Looking at options history for Eli Lilly LLY we detected 11 trades.
If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades with bullish expectations and 27% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $161,203 and 7, calls, for a total amount of $504,204.
Predicted Price Range
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $400.0 to $920.0 for Eli Lilly during the past quarter.
Volume & Open Interest Trends
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale activity within a strike price range from $400.0 to $920.0 in the last 30 days.
Eli Lilly Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BEARISH | 06/20/25 | $83.2 | $79.5 | $79.5 | $800.00 | $151.0K | 345 | 29 |
| LLY | CALL | SWEEP | BEARISH | 06/20/25 | $65.05 | $62.55 | $63.32 | $840.00 | $107.7K | 606 | 17 |
| LLY | CALL | TRADE | BULLISH | 01/17/25 | $398.45 | $392.45 | $397.55 | $400.00 | $79.5K | 374 | 0 |
| LLY | CALL | TRADE | BULLISH | 06/20/25 | $80.5 | $79.5 | $80.5 | $800.00 | $64.4K | 345 | 2 |
| LLY | PUT | TRADE | BULLISH | 01/17/25 | $55.1 | $52.3 | $53.35 | $830.00 | $53.3K | 1.0K | 1 |
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
After a thorough review of the options trading surrounding Eli Lilly, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Current Position of Eli Lilly
- Trading volume stands at 120,979, with LLY's price down by -0.54%, positioned at $795.24.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 55 days.
Expert Opinions on Eli Lilly
In the last month, 2 experts released ratings on this stock with an average target price of $998.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Reflecting concerns, an analyst from Wolfe Research lowers its rating to Outperform with a new price target of $1000. * An analyst from B of A Securities has revised its rating downward to Buy, adjusting the price target to $997.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
